BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 8408135)

  • 1. Treatment of giant-cell tumor of the pelvis.
    Sanjay BK; Frassica FJ; Frassica DA; Unni KK; McLeod RA; Sim FH
    J Bone Joint Surg Am; 1993 Oct; 75(10):1466-75. PubMed ID: 8408135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical observation of surgical management for recurrent giant cell tumor of bone].
    Kong Q; Yang J; Xing R; Tu C; Zhou Y; Zhang H; Duan H
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Jan; 27(1):36-40. PubMed ID: 23427489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative Denosumab With Curettage and Cryotherapy in Giant Cell Tumor of Bone: Is There an Increased Risk of Local Recurrence?
    Scoccianti G; Totti F; Scorianz M; Baldi G; Roselli G; Beltrami G; Franchi A; Capanna R; Campanacci DA
    Clin Orthop Relat Res; 2018 Sep; 476(9):1783-1790. PubMed ID: 30778015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicentric giant cell tumor of bone. Clinicopathologic analysis of thirty cases.
    Hoch B; Inwards C; Sundaram M; Rosenberg AE
    J Bone Joint Surg Am; 2006 Sep; 88(9):1998-2008. PubMed ID: 16951117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors of local recurrence of giant cell tumor of long bone after treatment: plain radiographs, pathology and surgical procedures.
    Chanchairujira K; Jiranantanakorn T; Phimolsarnti R; Asavamongkolkul A; Waikakul S
    J Med Assoc Thai; 2011 Oct; 94(10):1230-7. PubMed ID: 22145509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The analysis of the treatment of giant cell tumor of the pelvis and sacrum].
    Guo W; Tang XD; Li X; Ji T; Sun X
    Zhonghua Wai Ke Za Zhi; 2008 Apr; 46(7):501-5. PubMed ID: 18785558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risks and benefits of combining denosumab and surgery in giant cell tumor of bone-a case series.
    Müller DA; Beltrami G; Scoccianti G; Campanacci DA; Franchi A; Capanna R
    World J Surg Oncol; 2016 Nov; 14(1):281. PubMed ID: 27809843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment and outcome of giant cell tumors of the pelvis.
    Balke M; Streitbuerger A; Budny T; Henrichs M; Gosheger G; Hardes J
    Acta Orthop; 2009 Oct; 80(5):590-6. PubMed ID: 19916695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does Denosumab Change the Giant Cell Tumor Treatment Strategy? Lessons Learned From Early Experience.
    Agarwal MG; Gundavda MK; Gupta R; Reddy R
    Clin Orthop Relat Res; 2018 Sep; 476(9):1773-1782. PubMed ID: 30794215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wide resection versus curettage with adjuvant therapy for giant cell tumour of bone.
    Kamal AF; Simbolon EL; Prabowo Y; Hutagalung EU
    J Orthop Surg (Hong Kong); 2016 Aug; 24(2):228-31. PubMed ID: 27574268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Giant cell tumor of the extremity: retrospective analysis of 621 Chinese patients from one institution.
    Niu X; Zhang Q; Hao L; Ding Y; Li Y; Xu H; Liu W
    J Bone Joint Surg Am; 2012 Mar; 94(5):461-7. PubMed ID: 22398741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Giant cell tumor of bone.
    Eckardt JJ; Grogan TJ
    Clin Orthop Relat Res; 1986 Mar; (204):45-58. PubMed ID: 3514036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of giant-cell tumors of long bones with curettage and bone-grafting.
    Blackley HR; Wunder JS; Davis AM; White LM; Kandel R; Bell RS
    J Bone Joint Surg Am; 1999 Jun; 81(6):811-20. PubMed ID: 10391546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local recurrence of giant cell tumor of bone after intralesional treatment with and without adjuvant therapy.
    ; Becker WT; Dohle J; Bernd L; Braun A; Cserhati M; Enderle A; Hovy L; Matejovsky Z; Szendroi M; Trieb K; Tunn PU
    J Bone Joint Surg Am; 2008 May; 90(5):1060-7. PubMed ID: 18451399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of giant cell tumor of distal radius with limited soft tissue invasion: Curettage and cementing versus wide excision.
    Mozaffarian K; Modjallal M; Vosoughi AR
    J Orthop Sci; 2018 Jan; 23(1):174-179. PubMed ID: 29110910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soft tissue extension increases the risk of local recurrence after curettage with adjuvants for giant-cell tumor of the long bones.
    van der Heijden L; van de Sande MA; Dijkstra PD
    Acta Orthop; 2012 Aug; 83(4):401-5. PubMed ID: 22880716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrence of giant-cell tumors of the long bones after curettage and packing with cement.
    O'Donnell RJ; Springfield DS; Motwani HK; Ready JE; Gebhardt MC; Mankin HJ
    J Bone Joint Surg Am; 1994 Dec; 76(12):1827-33. PubMed ID: 7989388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrence of curetted and bone-grafted giant-cell tumours with and without adjuvant phenol therapy.
    Trieb K; Bitzan P; Lang S; Dominkus M; Kotz R
    Eur J Surg Oncol; 2001 Mar; 27(2):200-2. PubMed ID: 11289759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Giant cell tumors of the bones of the hand.
    Athanasian EA; Wold LE; Amadio PC
    J Hand Surg Am; 1997 Jan; 22(1):91-8. PubMed ID: 9018620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local recurrence after curettage treatment of giant cell tumors in peripheral bones: retrospective study by the GSF-GETO (French Sarcoma and Bone Tumor Study Groups).
    Gouin F; Dumaine V;
    Orthop Traumatol Surg Res; 2013 Oct; 99(6 Suppl):S313-8. PubMed ID: 23978709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.